Integrated Urinary Metabolomics and Artificial Intelligence for the Identification of Diagnostic, Prognostic, and Progression Biomarkers in Chronic Kidney Disease

Background: Chronic kidney disease (CKD) affects approximately 10% of the global population, and it is a critical challenge for public health worldwide. The integration of metabolomics with machine learning (ML) has emerged as a promising approach to enhancing disease diagnosis and prognosis. Objective: This study characterized the urinary metabolomic profiles of individuals with intermediate-to-advanced CKD and developed predictive models for disease diagnosis and prognosis. Methods: Urine samples from 129 participants, including healthy individuals and patients with CKD, were analyzed using liquid chromatography tandem mass spectrometry (LC-MS/MS). Multivariate analysis was performed to identify differences between groups. ML algorithms were the best for developing predictive models for the diagnosis, prognosis, and progression of CKD. Results: The results show the identities of 1499 metabolites. They also indicate that ML models effectively differentiated between healthy individuals and CKD patients, demonstrating high accuracy and specificity. The RF model was effective for diagnostic purposes, while the SVM showed superior performance in prognostic and disease progression predictions. The differentially expressed metabolites found, predominantly lipids, may serve as potential biomarkers for the detection and progression of CKD. Conclusions: The combination of urinary metabolomics with ML algorithms represents a promising, non-invasive approach for CKD diagnosis and follow-up, offering an alternative that may improve both the precision and personalization of disease management.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2026-11-13
DOI
https://doi.org/10.3390/diagnostics16223759
Primary Topic
Metabolomics and Mass Spectrometry Studies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Integrated Urinary Metabolomics and Artificial Intelligence for the Identification of Diagnostic, Prognostic, and Progression Biomarkers in Chronic Kidney Disease

Vivian Alonso‐Goulart, Mário Machado Martins, Tiara da Costa Silva, Nathália Rabello Silva et al.
1 links
Diagnostics
Metabolomics and Mass Spectrometry Studies
article

Integrated Urinary Metabolomics and Artificial Intelligence for the Identification of Diagnostic, Prognostic, and Progression Biomarkers in Chronic Kidney Disease

Vivian Alonso‐Goulart, Mário Machado Martins, Tiara da Costa Silva, Nathália Rabello Silva, Hebreia Oliveira Almeida-Souza, Marcus Vinícius de Pádua Netto, Luiz R Gourlart Filho, Letícia Cristina Machado de Sousa, Bianca Uliana Picolo, Ana Luiza Barbosa Ferreira, Michelly Yorrana Miranda de Araujo, Luciana Saraiva da Silva, Ana Laura Fonseca Orlandi
article en

Abstract

Background: Chronic kidney disease (CKD) affects approximately 10% of the global population, and it is a critical challenge for public health worldwide. The integration of metabolomics with machine learning (ML) has emerged as a promising approach to enhancing disease diagnosis and prognosis. Objective: This study characterized the urinary metabolomic profiles of individuals with intermediate-to-advanced CKD and developed predictive models for disease diagnosis and prognosis. Methods: Urine samples from 129 participants, including healthy individuals and patients with CKD, were analyzed using liquid chromatography tandem mass spectrometry (LC-MS/MS). Multivariate analysis was performed to identify differences between groups. ML algorithms were the best for developing predictive models for the diagnosis, prognosis, and progression of CKD. Results: The results show the identities of 1499 metabolites. They also indicate that ML models effectively differentiated between healthy individuals and CKD patients, demonstrating high accuracy and specificity. The RF model was effective for diagnostic purposes, while the SVM showed superior performance in prognostic and disease progression predictions. The differentially expressed metabolites found, predominantly lipids, may serve as potential biomarkers for the detection and progression of CKD. Conclusions: The combination of urinary metabolomics with ML algorithms represents a promising, non-invasive approach for CKD diagnosis and follow-up, offering an alternative that may improve both the precision and personalization of disease management.

DiagnosticsVol. 16(22)
Universidade Federal de Uberlândia (BR)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Good health and well-being
Metabolomics and Mass Spectrometry Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon